Dr. Satyendra Katewa

• Dr. Satyendra Katewa is a skilled and highly-educated Pediatric Hemato-Oncology & Bone Marrow Transplant Surgeon with +20 years of experience. 


• He holds professional memberships of the Rajasthan Medical Council, the fellowship of Pediatric Hematology - Indian Academy of Pediatrics, member of the European Society of Immunodeficiency Diseases (ESID), the International Society of Pediatric Oncology (SIOP), and the American Society of Bone Marrow Transplant among some other professional associations.


• He is considered as pioneer in starting Haploidentical (50% HLA matched) bone marrow transplants for children in India. He also started and established T-depleted (TCR αβ & B cell-depleted transplants) in India. He is one of the most senior pediatric transplanters in India


• Dr. Katewa completed his MBBS and PG from the Sardar Patel Medical College, University of Rajasthan, in 2004. He then earned DCH, DNB, and a fellowship.


• His specialization in the field of hematology includes conducting Bone Marrow Transplants, treating children with diseases and disorders of the blood, lymphomas, myelodysplastic syndrome, brain tumors, neuroblastoma, Wilms' tumor, germ cell tumor, bone, and soft tissue tumors, liver tumors, anemia, immune thrombocytopenic purpura and hemophilia among others.


• He has co-authored several papers in his field of expertise, which have been published in reputed medical journals. 

Scholarship for SIOP 2009, Sao Paulo, Brazil.
Best oral Presentation Award at the Scientific Paper Presentation at National Congress on Pediatric Critical Care, Delhi, India, 2007.
Oct 1995: Best Student award (Sardar Patel Medical College, Bikaner (Raj.), India.
... Read Less

• Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Hemophagocytic Lymphohistiocytosis.


•  Pre-Transplantation Suppression of Haemopoiesis Is Associated with a High Rate of Macrophage Activation Syndrome in Pt-Cy Haploidentical Transplantation for Haemoglobinopathies. 


•  Reduced Toxicity Alternate Donor Stem Cell Transplantation with Post Transplant Cyclophosphamide for Primary Immunodeficiency Disorders. Pediatric Blood and Cancer.